Small Wins, Personal Commitment and Concrete Solutions Add Up to Big Victories in Sustainability

Sustainability. Maybe it is your way of life, or you feel like it is a buzzword used and abused. Perhaps you are tired of hearing about it or convinced that society doesn’t do enough. Well, welcome to Switzerland, the country of Heidi, of mountains and chocolate, and where many are passionate about their environment and fight to preserve it. The team of Promega Switzerland is no exception. Take the General Manager, Mauro Ciglic, for example. He is someone who cares about people, nature, and the environment in the broadest sense. For him, sustainability is an attitude. It’s about questioning one’s lifestyle, behaviors, and habits, reflecting on what one can do personally, and continuously challenging oneself to be and do better for others and the environment. Mauro is aware that economic, social, and environmental aspects are intertwined and that changes in the environment, good or bad, directly impact people, thus society at large. As the person responsible for the Swiss Branch of Promega, Mauro can bring positive change using the company’s financial strength and workforce. He focuses on the opportunities and not the challenges and, with the team, works hard to bring concrete solutions.

“One of the hardest things for people to wrap their heads around tends to be the idea that small wins add up to big victories. However, if we want to make a big difference for the future of our planet and its people, we have to overcome our indifference towards so many small things in life.”

– Mauro Ciglic, General Manager, Promega Switzerland
Continue reading “Small Wins, Personal Commitment and Concrete Solutions Add Up to Big Victories in Sustainability”

Take a Break, Take A Walk!

Elderly father adult son and grandson out for a walk in the park.

For many of us, we’re used to getting our steps in when walking from one meeting room to the next. However, since the beginning of the COVID-19 pandemic, we shifted to new communication modes. Meetings transitioned to simply clicking from one zoom to the other, increasing the amount of time we stay sedentary. For those who are still working remotely, this is a reminder to make time for movement! Contrary to how long periods of sitting have negative effects on the body, walking has a long list of benefits. In the spirit of National Walking Day, here are some reasons why you should take a break and take a walk.

Continue reading “Take a Break, Take A Walk!”

GloMax® Instrument and NanoBiT® Technology Pave the Way for New Research Lab

Dr. Alsulami and the GloMax® Navigator  in his new research lab.

When setting up a new research lab, many researchers opt to outfit their new space with the technology and materials that got them through their academic studies. After graduating with his PhD from the University of Wisconsin-Madison, Dr. Tawfiq Alsulami will be traveling with a GloMax® Navigator Microplate Luminometer across the globe to continue his work as Assistant Professor in the Department of Food Science and Nutrition at King Saud University. Dr. Alsulami and his new lab at KSU will be using the NanoBiT® system to develop novel assays for the future of food testing.

Dr. Tawfiq Alsulami answered a few of our questions regarding his upcoming research at KSU and offered a few pieces of advice to new labs. Read the Q&A below:

Continue reading “GloMax® Instrument and NanoBiT® Technology Pave the Way for New Research Lab”

iGEM Team Explores Regenerative Spinal Cord Treatment with Promega Support

Today’s blog is written by KCL iGEM Team Leaders Alya Masoud Abdelhafid and Luke Bateman. Both in their third and final year at King’s College London, Alya is completing a BSc in Nutrition and Luke a BSc in Biochemistry.  

Every year, the International Genetically Engineered Machine competition (iGEM) offers high-school, undergraduate and post-graduate students the opportunity to conduct independent research using synthetic biology and genetic engineering to develop solutions to local and global problems.

More than 350 teams from around the world participate in iGEM, which culminates in a presentation at the global iGEM Giant Jamboree, attended by more than 6000 people every year. Here, novel research is presented amongst pioneers in synthetic biology, and outstanding projects are awarded prizes for their contribution to the greater scientific community. iGEM teams consistently produce ground-breaking solutions to modern challenges, many of which facilitate the development of multimillion-dollar companies and start-ups.

We are the King’s College London (KCL) iGEM team and are honored to be involved in the innovative and prestigious iGEM community.

Continue reading “iGEM Team Explores Regenerative Spinal Cord Treatment with Promega Support”

Avian Influenza H5N1: What You Should Know About the Current US Outbreak

As a lifelong Midwesterner, I’m accustomed to the short-lived, false springs of January and February. I know to save gleeful cries of “spring is here!” until the trees bud and I can hear the buzzing trill of red-winged blackbirds and the calls of other birds returning from their winter homes. But this spring, the return of birdsong is not all good news.

In January 2022, the state of South Carolina reported a case of highly pathogenic avian influenza in a wild bird—the first detected case of this virus subtype in the United States since 2016. Since then, the outbreak has spread. Two weeks ago my home state of Wisconsin reported its first case in a commercial chicken flock of nearly 3 million birds, one of the largest US flocks affected so far.

Continue reading “Avian Influenza H5N1: What You Should Know About the Current US Outbreak”

Using Tumor-Produced Neoantigens to Treat Lynch Syndrome

Lynch syndrome, named for American physician Dr. Henry T. Lynch, is a hereditary condition that causes a predisposition to several types of cancer, most commonly colorectal but to other types as well, including ovarian, endometrial and stomach cancer. The root of this disorder lies in a genetic defect known as DNA mismatch repair deficiency (or dMMR), which affects the process by which mistakes are repaired when our DNA is copied during cell division. People with Lynch syndrome can have up to an 80% increased lifetime risk of developing colorectal cancer, and are more susceptible to developing colorectal and other types of cancers at an earlier age. Accounting for 3-5% of all colon cancers, Lynch syndrome is an excellent target for preventative treatment, like a vaccine. Research exploring a Lynch syndrome vaccine seeks to harness the body’s innate immune response to target tumor cells and has yielded promising results.

Person receiving a vaccine. Lynch syndrome, a hereditary condition that causes a predisposition to several types of cancer is an excellent target for preventative treatment. Read more about how researchers have recently explored vaccines for Lynch syndrome
Continue reading “Using Tumor-Produced Neoantigens to Treat Lynch Syndrome”

Cultured Meat Viability Increases in Biotech

Cultured meat grows in a plastic dish in laboratory conditions.

The biotechnology industry has been powering through barriers standing between the lab and the dinner plate as cultured meat advances toward the market. Challenges like scaling up the technology and getting products to the market are significant, but future food demands are an even bigger obstacle. Earth’s population is projected to reach 10 billion people by 2050. Our current agricultural practices will not be able to meet the food demands. Therefore, we need to find alternative ways to produce food–like “growing” it in the lab.

Continue reading “Cultured Meat Viability Increases in Biotech”

Transforming Your Fear In Meetings

During the summer after my junior year of undergrad, I worked as a marketing intern for a health education nonprofit. I was a biology major, but by this time I knew I wanted to pursue a career in science writing, and this internship was my first real-world experience. It was an amazing summer, and by the time I walked into my exit interview, I was confident that my supervisor was pleased with my performance. However, she shared a piece of feedback that caught me off guard.

Continue reading “Transforming Your Fear In Meetings”

Superior Support to Automate and Scale-Up Your Workflows with Ease

Automating a workflow can be a tedious and challenging process that requires lots of time and resources. A helping hand can make all the difference, as it did for Stephanie Dormand, Molecular Supervisor at UniPath Women’s Health, a diagnostics lab located in Denver, Colorado. 

See how Promega Field Service Support staff helped one laboratory automate and scale-up sample processing to improve laboratory workflow. Promega Scientist at a liquid handler.

The women’s health molecular testing service at UniPath primarily relied on the tabletop Maxwell® RSC Instrument to conduct nucleic acid extractions using the Maxwell® Viral TNA Kit. As their testing needs grew, they required more throughput. Dormand worked with Promega Field Support Scientist Rick Grygiel to implement the Maxwell® HT Viral TNA Kit on the Tecan Fluent 780 liquid handler, raising their throughput from 16 to 96 samples per run. When COVID-19 struck, Dormand worked with Rick to quadruple their testing with the addition of another Fluent 780.

Continue reading “Superior Support to Automate and Scale-Up Your Workflows with Ease”

Antibody Correlates of Protection for mRNA Vaccine

Identifying correlates of protection, or biological markers that correlate with a certain level of protection from disease helps public health experts assess vaccination performance. Picture of a COVID-19 vaccine vial.

In the rapidly shifting context of a pandemic, public health officials need a way to quickly assess how vaccinations perform in changing situations. One approach is to identify correlates of protection, or biological markers that correlate with a certain level of protection from disease. This tool is used to assess the design and formulation of annual influenza vaccines, as immune system markers that correlate with protection from flu can give developers a sense of how effective the vaccine might be for different population groups. Though they are not a replacement for rigorous clinical trials, correlates of protection can provide meaningful and predictive data for vaccine developers with smaller trial sizes and less time.

A study published in November 2021 indicated that levels of binding antibodies and neutralizing antibodies for the SARS-CoV-2 virus in blood serum are correlates of protection for Moderna, Inc.’s COVE phase 3 clinical trial of their mRNA COVID-19 vaccine.

Continue reading “Antibody Correlates of Protection for mRNA Vaccine”